Pacgen Life Science Co. (PBS.V) (PBS) Stock Price, News & Analysis

Company Overview

Pacgen Life Science Corporation, a life sciences company, focuses on building a commercial platform to market and distribute consumer health products in North America. It markets its oral and skin care products under the P113+, DermaMed, DermaSoleil, and Deserving Health brand names. The company was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in May 2012. Pacgen Life Science Corporation was founded in 2004 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.03 to C$0.03
• 50-Day Range: C$0.03 to C$0.03
• 52-Week Range: C$0.01 to C$0.05
• Volume: 2,000 shs
• Average Volume: 63,601 shs
• Market Capitalization: C$1.94 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PBS Stock Analysis - Frequently Asked Questions

How have PBS shares performed this year?

Pacgen Life Science Co. (PBS.V)'s stock was trading at C$0.03 at the beginning of the year. Since then, PBS shares have increased by 0.0% and is now trading at C$0.03.
View the best growth stocks for 2025 here.

How do I buy shares of Pacgen Life Science Co. (PBS.V)?

Shares of PBS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:PBS
• CIK: N/A
• Web: www.pacgenlife.com
• Phone: +1-604-4364388
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 78.48
• Current Ratio: 0.81
• Quick Ratio: 0.40

Sales & Book Value

• Annual Sales: C$302,079.00
• Price / Sales: 6.44
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 30.00
• Book Value: C$0.00 per share
• Price / Book: -30.00

Miscellaneous

• Outstanding Shares: 64,816,000
• Free Float: N/A
• Market Cap: C$1.94 million
• Optionable: Not Optionable
• Beta: N/A